protein engineering

Abzena is a fully integrated biologics and bioconjugates CDMO+CRO, founded in 2001, providing discovery through commercial services for antibodies, ADCs, AOCs, RDCs, vaccines, fusion proteins, bispecifics and other complex biologics. It operates integrated facilities in San Diego CA, Bristol PA, and Cambridge UK, with corporate headquarters in Raleigh, North Carolina, and has partnered with over 500 customers globally.

analytics and bioassaysantibody discoverybioconjugationcell line developmentcGMP manufacturingcomplex chemistryformulation developmentHPAPI handlingimmunogenicity testingprocess developmenttechnology transfer

Advanced Protein Engineering Maximizing the Power of Proteins to Improve Patients’ Lives Read more Providing patients with easier to use, more effective protein therapeutics Learn more BOLDER SCIENCEBETTER MEDICINES We aspire to be a global leaderin the development of cost-effective, easy to useprotein therapeutics that positively impact patients’ lives. Empowering proteins to better treat diseases Bolder Bio Technology's diversified product pipeline includes treatments for hematological and endocrine disorders, cancer and infectious diseases. We intend to commercialize these products independently and through strategic alliances with corporate partners. Neutropenia / ARSGranulocyte Colony-Stimulating Factor (G-CSF) stimulates production…Learn more Multiple Sclerosis Multiple Sclerosis is a chronic central…Learn more Cancer / Alzheimer’s Disease / ARSWhite blood cells are critical.

bacterial fermentation of recombinant proteinscomputer-aided molecular modelinggene cloningin vitro mammalian cell assaysmutagenesisPEGylationprotein expression in bacteria, insect and mammalian cellsprotein purificationsite-specific bioconjugationstructural characterization of recombinant proteins

Callaghan Innovation is Aotearoa New Zealand's innovation agency, supporting businesses to turn ideas into commercial success through research and development expertise, funding, and connections. Named after Sir Paul Callaghan, it has supported innovators and entrepreneurs, helping advance R&D and commercialisation. It is now being disestablished as part of wider changes to the science, innovation and technology system, with services transferring to other organisations.

analytical servicesanti-microbial testingbench-scale researchbioactivity testingbioassays and analysisbioprocessingdownstream processingfermentationmicrobial screeningpilot to semi-commercial scale manufacturingprotein extractionscale-up trialssolvent and supercritical extraction

Cellibre uses biology as a manufacturing technology, employing nature's machinery to make products more sustainably. The company works in strain engineering, biochemistry and protein engineering, and precision fermentation, designing microbes that make products and moving production from farms to fermentation.

analytical chemistrybiochemistrybioprocessingprecision fermentationstrain engineering

EdiMembre is a company focused on edible membrane technologies, pioneering protein micro-architecture that enables future food, biology and therapeutics. It engineers proteins as functional materials, controlling membrane formation, transport and structure at the microscale to create performance attributes across nutrition, texture, stability, delivery, and biological interaction. The company designs micro and nanoporous membrane and membrane-like structures for advanced textural and functional applications on a scalable platform.

membrane formation controlmicro and nanoporous membrane designmicroscale structure control